Measure your patient’s response to lung cancer

Objective, blood-based prognostic results within 72 hours, independent of treatment choice and performance status

  

 

What is the VeriStrat® test?

  • Identifies a chronic inflammatory disease state associated with aggressive cancer
  • Objective prognostic test, independent of treatment choice and performance status
  • Facilitates disease state monitoring

Mechanism of Action

  • Multivariate test identifies the chronic elevation of acute phase reactants
  • These describe both acute and chronic inflammatory states, which are known to be associated with aggressive cancer
LEARN MORE ABOUT THE MECHANISM OF ACTION OF THE VERISTRAT TEST  
THE VERISTRAT® PROTEOMIC TEST IS COVERED BY MEDICARE AND MANY PRIVATE PAYERS.

Objective prognostic results independent of treatment choice and performance status

 

• Carbone et al. 2012 (BR.21)

Image Source: Carbone et al. 2012 (BR.21)

 

• Grossi et al. 2018 (NEXUS)
• Grossi et al. 2017 (BJC)
• Gregorc et al. 2014 (PROSE)
• Stinchcombe et al. 2013

Image Source: Grossi et al. 2017 (BJC)

 

• Fidler et al. 2018 (RUSH)
• Gadgeel et al. 2017 (LL8)
• Gregorc et al. 2014 (PROSE)
• Carbone et al. 2012 (BR.21)
• Amann et al. 2010
• Taguchi et al. 2007

Image Source: Amann et al. 2010

 

• Grossi et al. 2016

Image Source: Grossi et al. 2016

ROBUST, BLOOD-BASED TEST VALIDATED ACROSS 70+ STUDIES WITH A TOTAL OF 5500+ PATIENTS

VISIT OUR PUBLICATION DATA LIBRARY  

There are two sides to a VeriStrat test

VeriStrat identifies a chronic inflammatory disease state associated with aggressive cancer. VeriStrat classifies patients as:

  • VeriStrat Good: more likely to benefit from standard of care treatments
DOWNLOAD OUR TEST RESULT REPORT FOR VERISTRAT GOOD  

 

  • VeriStrat Poor: may benefit from an alternative treatment strategy
DOWNLOAD OUR TEST RESULT REPORT FOR VERISTRAT POOR  

Image Source: Grossi et al. 2017 (NEXUS Study)

Have the conversation

VeriStrat results set expectations for patients and facilitate prognostic conversations.

Patients with a VeriStrat Good result have a better overall prognosis, independent of treatment choice and other prognostic factors. Consider standard of care treatment options.

Patients with a VeriStrat Poor result consistently show decreased overall survival. Discuss an alternative patient management strategy. Consider:

  • Novel combination therapies
  • NGS testing for rare mutations
  • Non-platinum based regimen
  • Palliative Care

Source: Data on file – Biodesix 2018

Patients prefer to understand their cancer prognosis and expected outcome

  • Improved disease knowledge results in better quality care and quality of life for both the patient and caregiver.¹ ²
  • Over 95% of patients want to know their prognosis.³
  • Providing detailed information on prognosis decreases patient anxiety.​
  • Clinical guidelines encourage clear communication of prognosis with patients, caregivers and their families on an ongoing basis.

Reference: 1 Wright et al. Jama 300, no. 14 (2008): 1665-1673 2 Sullivan et al. Journal of palliative medicine 10, no. 4 (2007): 882-893. 3 Hagerty et al. Journal of clinical oncology 22, no. 9 (2004): 1721-1730.

“It is recommended that all physicians caring for patients with lung cancer should begin conversations about the patient’s prognosis and goals of care at the time of the diagnosis, and continue these throughout the course of the illness.”

Reprinted from CHEST, 143 /5(Suppl), Detterbeck et al., Executive Summary Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines / Palliative and End-of-Life Care in Lung Cancer, Page No. 37S, Copyright (2013), with permission from Elsevier.

We are committed to supporting your treatment strategies and improving the lives of patient’s with lung cancer.

SAVE TIME. 72-HOUR TURNAROUND.

SAVE TISSUE. ONE SIMPLE BLOOD DRAW.

TWO SIDES OF CANCER. GENOMIC & PROTEOMIC TESTING.

$0 OUT OF POCKET EXPENSE FOR MEDICARE AND MEDICAID PATIENTS.

Interested in ordering a test kit?

CLICK HERE TO MAKE AN ONLINE KIT REQUEST  

 

Get in touch

Contact us